| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |